SCHEMBL22764891

SCHEMBL22764891

C#C[C@]1(C(=O)NC)C[C@@H](n2cnc3c(NCCC)nc(C#Cc4ccc(Cl)s4)nc32)[C@H](O)[C@@H]1O

nearest known ligand 0.72

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 17/20 0.72
▸ SLC6A2 P23975 4/20 0.72
▸ SLC6A3 Q01959 4/20 0.72
▸ ADRB3 P13945 1/20 0.72
▸ ADORA1 P30542 3/20 0.64
▸ TMIGD3 P0DMS9 3/20 0.64
▸ ADRA2A P08913 1/20 0.64
▸ ADRA2B P18089 1/20 0.64
▸ SLC6A4 P31645 1/20 0.64
▸ ADORA2A P29274 1/20 0.60
▸ KCNH2 Q12809 2/20 0.59
▸ CYP1A2 P05177 1/20 0.57
▸ CYP3A4 P08684 1/20 0.57
▸ CYP2D6 P10635 1/20 0.57
▸ CYP2C19 P33261 1/20 0.57
▸ HTR2B P41595 1/20 0.56
▸ OPRD1 P41143 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22359594 0.89 ADORA3 (0.77) ADORA3SLC6A2SLC6A3ADRB3ADORA1
SCHEMBL22359595 0.85 ADORA3 (0.78) ADORA3SLC6A2SLC6A3ADRB3ADORA1
SCHEMBL23097553 0.85 ADORA3 (0.78) ADORA3SLC6A2SLC6A3ADRB3ADORA1
SCHEMBL22750287 0.84 ADORA3 (1.00) ADORA3SLC6A2SLC6A3ADRB3ADORA1
SCHEMBL16774267 0.84 ADORA3 (1.00) ADORA3SLC6A2SLC6A3ADRB3ADORA1
SCHEMBL24615123 0.84 ADORA3 (1.00) ADORA3SLC6A2SLC6A3ADRB3ADORA1
SCHEMBL21779328 0.84 ADORA3 (1.00) ADORA3SLC6A2SLC6A3ADRB3ADORA1
SCHEMBL20122069 0.84 ADORA3 (1.00) ADORA3SLC6A2SLC6A3ADRB3ADORA1
SCHEMBL20122135 0.83 ADORA3 (0.76) ADORA3SLC6A2SLC6A3ADRB3ADORA1
SCHEMBL24294732 0.82 SLC6A2 (0.72) ADORA3SLC6A2SLC6A3ADRB3ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020247540-A1 ADENOSINE ANALOGS FOR THE TREATMENT OF DISEASE BIOINTERVENE, INC. (US) 2020-12-10 — — WO disclosed
Send feedback